Identify common misconceptions among clinicians and patient-related factors that can interfere with the optimal utilization of LAIs in schizophrenia Assess the mechanisms of action, pharmacologic properties, and latest safety and efficacy data associated with LAIs for schizophrenia Outline best practices for utilizing LAIs according to the latest guidelines and recommendations Describe practical considerations and strategies to overcome barriers to the utilization of LAIs, including issues associated with storage, preparation, and administration Apply principles of patient-centered communication, including motivational interviewing, to facilitate patient understanding and acceptance of LAIs
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/24-uspc-101-4
- Start Date: 2024-06-28 05:00:00
- End Date: 2024-06-28 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours
Social Work: 0.25 hours - MOC Credit Details: ABS - 0.25 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest